Sleep-Related Headache and its Management

Current Treatment Options in Neurology

Volumn 15, Issue 6, 2013, Pages 704-722

  Singh, Niranjan N ^a   Sahota, Pradeep ^a  

^a University of Missouri   (United States)

Author keywords

Abortive treatment; Children; Cluster headache; Headache; Management; Migraine; Pregnancy; Prophylactic treatment; Sleep; Tension type headache; Triptans

Indexed keywords

ALMOTRIPTAN; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BOTULINUM TOXIN A; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; CYTOCHROME P450 3A4 INHIBITOR; CYTOCHROME P450 INHIBITOR; DIHYDROERGOTAMINE MESILATE; ELETRIPTAN; FROVATRIPTAN; INDOMETACIN; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NAPROXEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PROPRANOLOL; RIZATRIPTAN; STEROID; SULFANILAMIDE DERIVATIVE; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; TOPIRAMATE; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROATE SEMISODIUM; VERAPAMIL; ZOLMITRIPTAN;

ABDOMINAL PAIN; ACRAL PARESTHESIA; AGRANULOCYTOSIS; ANEMIA; ARTICLE; ATAXIA; BEDTIME DOSAGE; BLURRED VISION; BRADYCARDIA; BRAIN DEPTH STIMULATION; BRAIN DISEASE; BRAIN PSEUDOTUMOR; BRONCHOSPASM; BURNING SENSATION; CHEST PRESSURE; CHEST TIGHTNESS; CHRONIC TENSION HEADACHE; CLOSED ANGLE GLAUCOMA; CLUSTER HEADACHE; COGNITIVE DEFECT; COMORBIDITY; CONFUSION; CONGENITAL MALFORMATION; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DIABETES INSIPIDUS; DISEASE ASSOCIATION; DIZZINESS; DORSAL RAPHE NUCLEUS; DROWSINESS; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG INDUCED HEADACHE; FAINTNESS; FATIGUE; GINGIVA HYPERPLASIA; HAIR LOSS; HEADACHE; HEART ARRHYTHMIA; HEART BLOCK; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERAMMONEMIA; HYPERTENSION; HYPNIC HEADACHE; HYPOTHALAMUS; HYPOTHYROIDISM; HYPOXEMIA; IMPOTENCE; INSOMNIA; LEG SWELLING; LIFESTYLE MODIFICATION; LIVER TOXICITY; LOCUS CERULEUS; MENTAL DISEASE; METABOLIC ACIDOSIS; METALLIC TASTE; MIGRAINE; MUSCLE TIGHTNESS; MUSCLE WEAKNESS; MYOPIA; NAUSEA; NECK TIGHTNESS; NEPHROLITHIASIS; NEURAL TUBE DEFECT; OLIGOHYDROSIS; ORTHOSTATIC HYPOTENSION; OXYGEN THERAPY; PANCREATITIS; PARESTHESIA; PAROXYSMAL HEMICRANIA; PATIENT EDUCATION; PERIAQUEDUCTAL GRAY MATTER; PHOTOSENSITIVITY; POLYSOMNOGRAPHY; POLYURIA; POSITIVE END EXPIRATORY PRESSURE; QT PROLONGATION; REM SLEEP; SEIZURE; SLEEP; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP RELATED HEADACHE; SLEEP STAGE; SWEAT GLAND DISEASE; TACHYCARDIA; TASTE DISORDER; THORAX DISEASE; TRANSFORMED MIGRAINE; TREMOR; URINE RETENTION; VASOSPASM; VOMITING; WEAKNESS; XEROSTOMIA;

EID: 84892188319     PISSN: 10928480     EISSN: 15343138     Source Type: Journal    
DOI: 10.1007/s11940-013-0258-1     Document Type: Article

References (70)

1. Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193-210.
2. Sjaastad O, Bakketeig LS. Cluster headache prevalence. Vaga study of headache epidemiology. Cephalalgia. 2003;23(7):528-33.
3. Paiva T, Batista A, Martins P, Martins A. The relationship between headaches and sleep disturbances. Headache. 1995;5(10):590-6.
4. Rains JC, Poceta JS, Penzien DB. Sleep and headaches. Curr Neurol Neurosci Rep. 2008;8(2):167-75.
5. Nobre ME, Leal AJ, Filho PM. Investigation into sleep disturbance of patients suffering from cluster headache. Cephalalgia. 2005;25(7):488-92.
6. Mitsikostas DD, Vikelis M, Viskos A. Refractory chronic headache associated with obstructive sleep apnoea syndrome. Cephalalgia. 2008;28(2):139-43.
7. Vgontzas A, Cui L, Merikangas KR Are sleep difficulties associated with migraine attributable to anxiety and depression? Headache. 2008;48(10):1451-9.
8. Ohayon MM. Prevalence and risk factors of morning headaches in the general population. Arch Intern Med. 2004;164(1):97-102.
9. Barbanti P, Fabbrini G, Aurilia C, et al. A case-control study on excessive daytime sleepiness in episodic migraine. Cephalalgia. 2007;27(10):1115-9.
10. Silberstein SD, Lipton RB, Dalessio DJ. Overview, diagnosis, and classification of headache. In: Silberstein SD, Lipton RB, Dodick DW, (Eds). Wolffs headache and other head pain. 8th edition. Oxford University Press; 2007.
11. Rains JC, Poceta JS. Sleep-related headaches. Neurol Clin. 2012;30(4):1285-98.
12. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, second edition. Cephalalgia. 2004;24 Suppl 1:1-151.
13. Alberti A, Mazzotta G, Gallinella E, et al. Headache characteristics in obstructive sleep apnea and insomnia. Acta Neurol Scand. 2005;111:309-16.
14. Dexter JD, Weitzman ED. The relationship of nocturnal headaches to sleep headaches to sleep stage patterns. Neurology. 1970;20:413-519.
15. Fox AW, Davis RL. Migraine chronobiology. Headache. 1998;38(6):436-41.
16. Goder R, Fritzer G, Kapsokalvyas A, et al. Polysomnographic findings in nights preceding a migraine attack. Cephalalgia. 2001;21:31-7.
17. Ødegård SS, Engstrøm M, Sand T, Stovner LJ, Zwart JA, Hagen K. Associations between sleep disturbance and primary headaches: the third Nord-Trøndelag Health Study. J Headache Pain. 2010;11(3):197-206.
18. Raskin NH. The hypnic headache syndrome. Headache. 1988;28:534-6.
19. Evers S, Goadsby PJ. Hypnic headache: clinical features, pathophysiology, and treatment. Neurology. 2003;60(6):905-9.
20. Pinessi L, Rainero I, Cicolin A, et al. Hypnic headache syndrome: association with REM sleep. Cephalalgia. 2003;23:150-4.
21. Dodick DW, Mosek AC, Campbell JK. The hypnic ('alarm clock') headache syndrome. Cephalalgia. 1998;18:152-6.
22. Holle D, Wessendorf TE, Zaremba S, et al. Serial polysomnography in hypnic headache. Cephalalgia. 2011;31(3):286-90.
23. Kayed K, Godtlibsen OB, Sjaastad O. Chronic paroxysmal hemicranias IV: "REM sleep locked" nocturnal headache attacks. Sleep. 1978;1(1):91-5.
24. Kayed K, Sjaastad O. Nocturnal and early morning headaches. Ann Clin Res. 1985;17:243-6.
25. Karli N, Zarifoglu M, Calisir N, Akgoz S. Comparison of pre-headache phases and trigger factors of migraine and episodic tension-type headache: do they share similar clinical pathophysiology? Cephalalgia. 2005;25(6):444-51.
26. Sachs C, Svanborg E. The exploding head syndrome: polysomnographic recordings and therapeutic suggestions. Sleep. 1991;14(3):263-6.
27. Tepper SJ, Stewart WJ. Medication-overuse headache. Continuum. 2012:18(4):807-22.
28. Calhoun AH, Ford S. Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache. 2007;47(8):1178-83.
29. Graham JR Wolff HG Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry. 1938;39:737.
30. Rizzoli PB. Acute and preventive treatment of migraine. Continuum. 2012:18(4):764-82.
31. Loder E. Triptan therapy in migraine. N Engl J Med. 2010;363(1):63-70.
32. Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a metaanalysis of 53 trials. Cephalalgia. 2002;22(8):633-58.
33. Baron EP, Tepper SJ. Revisiting the role of ergots in the treatment of migraine and headache. Headache. 2010;50(8):1353-61.
34. Saper JR, Silberstein S. Pharmacology of Dihydroergotamine and evidence for efficacy and safety in migraine. Headache. 2006;46(4):S171-81.
35. Klapper JA, Stanton J. Clinical experience with patient administered subcutaneous Dihydroergotamine mesylate in refractory headaches. Headache. 1992;32(1):21-3.
36. Ramadan NM. Current trends in migraine prophylaxis. Headache. 2007;47 Suppl 1:S52-7.
37. Solomon S. Major therapeutic advances in the past 25 years. Headache. 2007;47 Suppl 1:S20-2.
38. Evans RW, Rizzoli P, Loder E, Bana D. Beta-blockers for migraine. Headache. 2008;48(3):455-60.
39. Dodick DW, Smith TR Becker WJ, et al. Botulinum neurotoxin type A for treatment of chronic migraine: PREEMPT 2 trial double-blind phase. Presented at: the International Headache Congress; Philadelphia, Pennsylvania; September 9-13, 2009.
40. Mauskop A. Nonmedication, alternatives, and complimentary treatments for migraine. Continuum. 2012:18(4):796-806.
41. Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, et al. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with Zolmitriptan for acute migraine: a randomized, placebo-controlled, parallel-treatment trial. Lancet. 2008;372(9656):2115-23.
42. Färkkilä M, Diener HC, Géraud G, Láinez M, Schoenen J, Harner N, et al. COL MIG-202 study group. Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomized, placebo-controlled, parallel-group, dose-ranging study. Lancet Neurol. 2012;11(5):405-13.
43. Bartsch T, Paemeleire K, Goadsby PJ. Neurostimulation approaches to primary headache disorders. Curr Opin Neurol. 2009;22(3):262-8.
44. Jürgens TP, Leone M. Pearls and pitfalls: neurostimulation in headache. Cephalalgia. 2013;33(8):512-25.
45. Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ. ONSTIM Investigators. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011;31(3):271-85.
46. Tobin J, Flitman S. Occipital nerve blocks: when and what to inject? Headache. 2009;49:1521-33.
47. Ashkenazi A, Matro R Shaw JW, et al. Greater occipital nerve block using local anesthetics alone or with triamcinolone for transformed migraine: a randomized comparative study. J Neurol Neurosurg Psychiatry. 2008;79:415-7.
48. Babineau S, Geen M. Headaches in children. Continuum. 2012:18(4):753-68.
49. Brandes JL. The influence of estrogen on migraine: a systematic review. JAMA. 2006;295(15):1824-30.
50. Brandes LS, Green M. Migraine in women. Continuum. 2012:18(4):835-52.
51. Dodick DW, Capobianco DJ. Treatment and management of cluster headache. Curr Pain Headache Rep. 2001;5(1):83-91.
52. Nesbitt AD, Goadsby PJ. Cluster headache. BMJ. 2012(11);344:e2407.
53. Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA. 2009;302(22):2451-7.
54. Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ. Effectiveness of intranasal Zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Arch Neurol. 2006;63(11):1537-42.
55. van Vliet JA, Bahra A, Martin V, Ramadan N, Aurora SK, Mathew NT, et al. Intranasal Sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology. 2003;60(4):630-3.
56. Bussone G, Leone M, Peccarisi C, Micieli G, Granella F, Magri M, et al. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache. 1990;30(7):411-7.
57. Goadsby PJ. Trigeminal autonomic Cephalalgias. Continuum. 2012;18(4):883-95.
58. Cohen AS, Matharu MS, Goadsby PJ. Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. Neurology. 2007;69(7):668-75.
59. Leone M, Proietti Cecchini A, Franzini A, Broggi G, Cortelli P, Montagna P, et al. Lessons from 8 years' experience of hypothalamic stimulation in cluster headache. Cephalalgia. 2008;28(7):787-97.
60. Burns B, Watkins L, Goadsby PJ. Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients. Lancet. 2007;369(9567):1099-106.
61. Donnet A, Lantéri-Minet M. A consecutive series of 22 cases of hypnic headaches in France. Cephalalgia. 2009;29:928-34.
62. Lanteri-Minet M, Donnet A. Hypnic headache. Curr Pain Headache Rep. 2010;14(4):309-15.
63. Morgenthaler TI, Kapen S, Lee-Chiong T, Alessi C, Boehlecke B, Brown T, et al. Standards of practice committee; American Academy of Sleep Medicine. Practice parameters for the medical therapy of obstructive sleep apnea. Sleep. 2006;29(8):1031-5.
64. Nath Zallek S, Chervin RD. Improvement in cluster headache after treatment for obstructive sleep apnea. Sleep Med. 2001;1(2):135-8.
65. Kiely JL, Murphy M, McNicholas WT. Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study. Eur Respir J. 1999;13(5):1086-90.
66. Kaniecki RG. Tension-type headache. Continuum. 2012;18(4):823-34.
67. Fumal A, Schoenen J. Tension-type headache: current research and clinical management. Lancet Neurol. 2008;7(1):70-83.
68. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA. 1998;279(5):381-3.
69. Cohen AS, Kaube H. Rare nocturnal headaches. Curr Opin Neurol. 2004;17(3):295-9.
70. Green MW. The exploding head syndrome. Curr Pain Headache Rep. 2001;5:279-80.